TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 101 filers reported holding TURNING POINT THERAPEUTICS I in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $258,000 | -17.6% | 3,300 | 0.0% | 0.00% | -25.0% |
| Q1 2021 | $313,000 | -22.1% | 3,300 | 0.0% | 0.00% | -20.0% |
| Q4 2020 | $402,000 | +83.6% | 3,300 | +32.0% | 0.01% | +66.7% |
| Q3 2020 | $219,000 | -73.2% | 2,500 | -80.2% | 0.00% | -72.7% |
| Q2 2020 | $818,000 | +44.8% | 12,650 | 0.0% | 0.01% | +22.2% |
| Q1 2020 | $565,000 | -29.1% | 12,650 | 0.0% | 0.01% | +12.5% |
| Q4 2019 | $797,000 | +67.4% | 12,650 | 0.0% | 0.01% | +60.0% |
| Q3 2019 | $476,000 | -7.6% | 12,650 | 0.0% | 0.01% | -16.7% |
| Q2 2019 | $515,000 | – | 12,650 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,737,297 | $176,802,000 | 6.75% |
| MPM BioImpact LLC | 308,686 | $19,938,000 | 5.30% |
| Burrage Capital Management LLC | 77,172 | $4,985,000 | 3.49% |
| Orbimed Advisors | 2,745,327 | $177,321,000 | 2.50% |
| Parkman Healthcare Partners LLC | 110,318 | $7,125,000 | 2.01% |
| SECTORAL ASSET MANAGEMENT INC | 284,486 | $18,375,000 | 1.69% |
| First Light Asset Management, LLC | 192,829 | $12,455,000 | 1.45% |
| Asymmetry Capital Management, L.P. | 22,608 | $1,460,000 | 1.12% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 35,000 | $2,236,000 | 0.74% |
| Prosight Management, LP | 25,602 | $1,654,000 | 0.71% |